SAFElife™ T-Dip® 1 Panel (Single Panel) Rapid Drug Test Dip Card, CLIA Waived, 25/Box
Brand : SAFElife™
- Per Each:
- 25
SAFElife™ T-Dip® 1-Panel, CLIA Waived Rapid Drug Test Dip Card, 25/Box
The T-Dip® 1 Panel (Single Panel) Drug Test Dip Card is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- FDA 510(K) Cleared
- Health Canada Approved
- Up to 99% Accurate & Adheres to SAMSHA Cutoffs
- SAMHSA Lab GC/MS Confirmation optional
- Immediate Results
- Results Remain Valid For Up To 4 Hours After Test Initiation
- Shelf-life 24 months from date of manufacture
SAFElife™ T-Dip® Urine Drug Tests are available with the following SAMSHA Approved Cutoff Levels | ||||
Drug Name | Abbreviation | Cutoff | Minimum Detection Time* | Maximum Detection Time* |
Amphetamine | AMP | 1000 ng/ml | 2-7 hours | 2-4 days |
Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks |
Benzodiazepines | BZO | 300 ng/ml | 2-7 hours | 1-4 days |
Buprenorphine | BUP | 10 ng/ml | 2-7 hours | 2-3 days |
Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days |
Ecstasy | MDMA | 500 ng/ml | 2-7 hours | 2-4 days |
Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days |
Methadone | MTD | 300 ng/ml | 3-8 hours | 1-3 days |
Methamphetamine | mAMP | 1000 ng/ml | 2-7 hours | 2-4 days |
Morphine | MOP (OPI-300) | 300 ng/ml | 2 hours | 2-3 days |
Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days |
Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days |
Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days |
Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days |
Propoxyphene | PPX | 300 ng/ml | 2-7 hours | 2-3 days |
* Detection times are not guaranteed. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |